Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06086054 | Effect of a Childcare Resource on Cervical Cancer Prevention | terminated | N/A | 65 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT02140021 | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer | terminated | N/A | 409 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT04278326 | Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments(ORGANOIDES) | terminated | N/A | 14 | Centre Hospitalier Régional d'OrléansOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT02735109 | Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors | terminated | N/A | 10 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT02238938 | Piecemeal Versus En Bloc Resection of Large Rectal Adenomas(PERLA) | terminated | N/A | 110 | Universitätsklinikum Hamburg-EppendorfOTHER | 2 | Jun 29, 2023 | clinicaltrials |
| NCT02503111 | The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men(HPV-SAVE) | terminated | N/A | 71 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03505372 | Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia | terminated | N/A | 5 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT00682552 | Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence | terminated | N/A | 14 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 28, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Aug 5, 2025source: clinicaltrials